Evidence map›Paper›PMID 34477019›Full record

ArticleExpert review of anti-infective therapy2022

Detection of SARS-CoV-2 by antigen ELISA test is highly swayed by viral load and sample storage condition.

Nihad Adnan, Shahad Saif Khandker, Ahsanul Haq, Mousumi Akter Chaity, Abdul Khalek, Anawarul Quader Nazim, Taku Kaitsuka, Kazuhito Tomizawa, Masayasu Mie, Eiry Kobatake and 5 more

Open access · greenAbstract read
In one paragraph

Article in Expert review of anti-infective therapy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.8field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 9 institutions in 3 countries.

Nihad AdnanDepartment of Microbiology, Jahangirnagar University, Dhaka, Bangladesh.ORCID 0000-0002-4999-4793
Shahad Saif KhandkerDepartment of Research and Development, Gonoshasthaya-RNA Molecular Diagnostic & Research Center, Dhaka, Bangladesh.ORCID 0000-0003-4724-0645
Ahsanul HaqDepartment of Research and Development, Gonoshasthaya-RNA Molecular Diagnostic & Research Center, Dhaka, Bangladesh.
Mousumi Akter ChaityDepartment of Microbiology, Jahangirnagar University, Dhaka, Bangladesh.
Abdul KhalekDepartment of Diagnostic Laboratory, Enam Medical College and Hospital, Dhaka, Bangladesh.
Anawarul Quader NazimDepartment of Diagnostic Laboratory, Enam Medical College and Hospital, Dhaka, Bangladesh.
Taku KaitsukaDepartment of Pharmaceutical Sciences, School of Pharmacy, International University of Health and Welfare, Fukuoka, Japan.ORCID 0000-0001-5556-8179
Kazuhito TomizawaDepartment of Molecular Physiology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.ORCID 0000-0002-5663-2627
Masayasu MieDepartment of Life Science and Technology,School of Life Science and Technology, Tokyo Institute of Technology, Yokohama, Japan.ORCID 0000-0003-2255-3346
Eiry KobatakeDepartment of Life Science and Technology,School of Life Science and Technology, Tokyo Institute of Technology, Yokohama, Japan.ORCID 0000-0002-2468-5804
Sohel AhmedDepartment of Biochemistry and Molecular Biology, Jahangirnagar University, Dhaka, Bangladesh.
Nor Azlina A AliDepartment of Physical Rehabilitation Sciences, Kulliyyah of Allied Health Sciences, International Islamic University Malaysia, Kuantan, Malaysia.ORCID 0000-0001-9139-6095
Mohib Ullah KhondokerDepartment of Community Medicine, Gonoshasthaya Samaj Vittik Medical College, Dhaka, Bangladesh.ORCID 0000-0003-1021-4435
Mainul HaqueThe Unit of Pharmacology, Faculty of Medicine and Defence Health Universiti Pertahanan, Nasional Malaysia (National Defence University of Malaysia), Kuala Lumpur, Malaysia.ORCID 0000-0002-6124-7993
Mohd Raeed JamiruddinDepartment of Pharmacy, Brac University, Dhaka, Bangladesh.ORCID 0000-0003-0495-4808
Jahangirnagar University · BDEnam Medical College & HospitalTokyo Institute of Technology · JPBRAC University · BDFukuoka International University · JPGono University · BDInternational Islamic University Malaysia · MYKumamoto University · JPNational Defence University of Malaysia · MY

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRapid increase in COVID-19 suspected cases has rendered disease diagnosis challenging, mainly depending upon RT-qPCR. Reliable, rapid, and cost-effective diagnostic assays that complement RT-qPCR should be introduced after thoroughly evaluating their performance upon various disease phases, viral load, and sample storage conditions.

objectiveWe investigated the correlation of cycle threshold (Ct) value, which implies the viral load and infection phase, and the storage condition of the clinical specimen with the diagnosis of SARS-CoV-2 through our newly developed in-house rapid enzyme-linked immunosorbent assay (ELISA) system.

methodNaso-oropharyngeal samples of 339 COVID-19 suspected cases were collected and evaluated through RT-qPCR that were stored up to 30 days in different conditions (i.e. -80°C, -20°C and initially at 4°C followed by -80°C). The clinical specimens were evaluated with our in-house ELISA system after finalizing the assay method through checkerboard assay and minimizing the signal/noise ratio.

resultThe ELISA system showed the highest sensitivity (92.9%) for samples with Ct ≤30 and preserving at -80°C temperature. The sensitivity reduced proportionally with increasing Ct value and preserving temperature. However, the specificity ranged between 98.3% and 100%.

conclusionThe results indicate the necessity of early infection phase diagnosis and lower temperature preservation of samples to perform rapid antigen ELISA tests.

Indexed as

COVID-19SARS-CoV-2Specimen HandlingViral LoadEnzyme-Linked Immunosorbent AssayHumansSensitivity and SpecificityantigenCOVID-19cycle thresholdELISAnucleocapsidrapidSARS-CoV-2

Identifiers

PMID34477019
PMCPMC8442762
OpenAlexW3196530018

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.